miRNA-128 and miRNA-223 Regulate Cholesterol-Mediated Drug Resistance in Breast Cancer

Three breast cancer cell lines were treated with a combination of 1 μM tamoxifen and 10 μM of a cholesterol depleting agent following transfection with a miR-128 inhibitor or a miR-223 mimic.